Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CHIR-Net
With
Technical University of Munich
The trial is designed to show that neoadjuvant radiotherapy followed by surgery improves local recurrence free survival compared to surgery alone in patients with resectable adenocarcinoma of the pancreatic head.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed adenocarcinoma of the pancreatic head
Age ≥ 18 years
Signed informed consent
ECOG performance status of 0-2
You may not be if
Curative resection is not feasible or presence of metastatic disease
